Drug intelligence / Profile preview

Vitlife-Q

Development stage: Unknown
Lead developer: Meri Odin Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Vitlife-Q is a dietary supplement formulated as capsules, developed and marketed by Meri Odin Life Sciences, a division of Meridian Medicare. It contains a combination of coenzyme Q10 (CoQ10), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), lycopene, and selenium. The supplement is designed to provide comprehensive antioxidant and nutritional support to promote overall cellular health and cardiovascular wellness.

Brand names: Vitlife-QVitlife-Q Capsules

Beyond the preview

Go deeper on Vitlife-Q.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitlife-Q.